About our research:
Oslo Myeloma Center is the largest center for clinical myeloma research in the Nordic region.
In January 2026, our center was awarded Clinical Trial Center of the Year (Årets Senter) in Norway. The center contributes to approximately 5% of all global industry-sponsored myeloma trials.
Since 2015, Oslo Myeloma Center has enrolled over 1019 patients in 67 clinical studies, including newly diagnosed and relapsed/refractory patients across Phase 1, 2, 3 and 4 trials.
